Research study Program year 2019 Source: CMS Open Payments

EntyvioVedolizumab Long Term Study

Research payments

$1,248,246

168 payments

Through program year 2019, $1,248,246 in research payments was reported against EntyvioVedolizumab Long Term Study, across 168 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..

Paid by
Takeda Pharmaceuticals U.S.A., Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

1 row
Year Kind Amount Payments
2019 Research $1,248,246 168

Breakdown

Who paid Research payments · program year 2019
  1. Takeda Pharmaceuticals U.S.A., Inc. $1,248,246 168 payments
Who received the money Research payments · program year 2019
  1. Infusion Associates PC Organisation paid for research $180,540 3 payments
  2. University Of North Carolina At Chapel Organisation paid for research $62,242 3 payments
  3. Medical Research Center Of Organisation paid for research $55,980 3 payments
  4. Ahs Hospital Corp Organisation paid for research $49,465 7 payments
  5. New York University School Of Medicine Organisation paid for research $46,360 3 payments
  6. Loyola University Chicago Organisation paid for research $45,075 3 payments
  7. Vanderbilt University Medical Center Organisation paid for research $45,000 6 payments
  8. Medical College Of Wisconsin INC Organisation paid for research $44,792 3 payments
  9. The Geneva Foundation Organisation paid for research $43,289 4 payments
  10. Adventist Health System Sunbelt INC Organisation paid for research $39,554 2 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program year 2019
  1. Other $1,237,376 166 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record